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Abstract 
Background: Pituitary tumor apoplexy is 
a clinical syndrome characterized by abrupt 
onset of a severe headache, nausea, vertigo, 
meningismus, and/or decreased level of 
consciousness. 
Case report: we report a case of a 56-year 
old man presented to medical attention 
with sudden severe headache, nausea, 
vomiting, dizziness, diplopia and blurring 
of vision. Computer tomography and 
contrast-enhanced magnetic resonance 
imaging of the head proved a large sellar 
tumor with extension to the sphenoid 
sinus, suprasellar region and both 
cavernous sinuses, predominantly on the 
right side with intratumoral hemorrhagic 
zones and the hemorrhagic accumulation in 
the posterior horns of the lateral ventricles. 
The treatment of choice was 
transsphenoidal approach and the patient 
was discharged in a good condition, 
completely oriented, without other 
neurological signs. 
Conclusions: Pituitary apoplexy remains 
a potentially life-threatening disease. Its 
presentation may vary from relatively 
benign symptoms to major neurological 
deficits and even death. Its early recognition 
and treatment are vital. 
Keywords: pituitary apoplexy, 
intraventricular hemorrhage, infarction, 
hemorrhage 
Background 
Pituitary tumor apoplexy is an 
uncommon but well-described clinical 
syndrome characterized by a constellation 
of severe signs and symptoms like: sudden 
headache, visual impairment, restriction of 
visual fields, paresis of ocular muscles, 
impaired consciousness. Clinical syndrome 
is generally consequent to the following: 
subarachnoid extravasation of blood and 
dural irritation, cranial nerve and 
hemispheric compression from lateral or 
superior extention of necrotic and/or 
hemorrhagic material, endocrine 
abnormalities from acute pituitary 
dysfunction. (9, 11) 
Clinical presentation of pituitary 
apoplexy varies from a clinically relatively 
benign event to a catastrophic episode with 
severe neurological deficit, endocrine 
failure, or even deth. (9) 
Computer tomogtaphy scans may reveal 
the hyperdensity of acute hemorrhage if 
obtained within 3 or 4 days after the event 
or demonstrate the mixed density of acute 
blood and necrotic tissue. The greater 
sensitivity, precision, and tissue definition 
of MR imaging usually reveal the 
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heterogeneous intensity of hemorrhage, 
edematous pituitary gland, and necrotic 
tissue, leading more readily to a 
diagnosis.(9) 
The transsphenoidal approach is safe and 
efficient choise for treating pituitary 
apoplexy. The vulnerable optic pathway, 
which is severely compressed and which 
becomes edematous during the acute stage 
should not be directly manipulated through 
the transcranial approach but should be 
decompressed by transsphenoidal 
surgery.(1) 
Case report 
This 56-year old man presented to 
medical attention with sudden severe 
headache, nausea, vomiting, dizziness, 
diplopia and blurring of vision. One day 
later the patient was admitted to the 
neurosurgical department of our 
institution. 
Examination On examination the patient 
was confused, sometimes excited, and 
disoriented as to place, time, and situation, 
the symptoms of intracranial hypertension 
was also present. Blood pressure was 120/80 
mmHg, and the pulse rate 110 beats/min. 
Ophtalmological examination revealed that 
there was ptosis on the right eyelid, the 
right eye was deviated outward and slightly 
downward. We also found a dilated 
nonreactive pupil and paresis of 
accommodation on the right eye. The visual 
acuity of both eyes was reduced; there was 
no visual field defects. The funduscopic 
examination was normal.  
Neurological examination showed 
positive meningeal symptoms. The 
remainder of the physical examination was 
normal. 
Emergent computer tomography (Figure 
1) and contrast-enhanced magnetic 
resonance imaging (Figure 2) of the head 
was performed and demonstrated a large 
sellar tumor with extension to the sphenoid 
sinus, suprasellar region and both 
cavernous sinuses, predominantly on the 
right side. We noted the intratumoral 
hemorrhagic zones and the hemorrhagic 
accumulation in the posterior horns of the 
lateral ventricles. The CT and IRM scans 
showed a right temporal arachnoid cyst. 
The endocrinological testing was also 
performed and did not reveal any 
abnormalities. 
Surgical approach 
The surgery was performed promptly. In 
this case we chose the emergent transnasal 
transsphenoisal approach combined with 
steroid treatment. The trassphenoidal 
surgery was carried out under general 
anesthesia and oral endotracheal intubation. 
Prior to operation the nasal mucosa was 
infiltrated with saline solution in order to 
lessen bleeding and to facilitate dissection 
of the mucosa from de septum. Under 
microscopic magnification, using a nasal 
speculum the septal mucosa was incised in 
a superoinferior direction. 
Dissection was carried out posteriorly 
along the septum until the sphenoid prow 
was identified. The cartilaginous septum is 
fractured toward the contralateral side. In 
this stage we identified the anterior wall of 
the sphenoid sinus which was resected. 
After the anterior sphenoidotomy was 
performed and the sphenoid mucosa was 
removed we saw the entire cavity of the 
sinus filled with tumor – a heterpgeneous, 
reddish mass with hemorrhagic parts and 
fluid texture. After this portion of tumor 
was removed we moved to the intrasellar 
part of the tumor. First we removed the 
inferior part of the intrasellar tumor, then 
the lateral part was resected beginning on 
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the site opposite the suspected location of 
the normal pituitary gland. In this stage 
attention must be paid not to harm the 
structures of the cavernous sinus. The last 
part resected was the superior part. As the 
tumor was removed superiorly the 
diaphragm of the sella prolapsed into the 
operative field. Following tumor removal 
the sellar defect must be reconstructed to 
prevent the prolapse of the suprasellar 
structures and to prevent CSF leakage. 
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Figure 1 Cerebral CT scans: large sellar tumor with extension to the sphenoid sinus, suprasellar region and 
both cavernous sinuses, predominantly on the right side, intraventricular hemorrhage 
 
     
 
     
Figure 2 Cerebral MR: sellar/suprasellar tumor expanding the sella nad encasing both carotid arteries 
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The defect was filled with surgical and 
gelaspone. The nasal septum was returned 
to the midline position and a tampon 
consisting of vaseline impregnated gause 
was inserted into both nasal cavities and 
removed 24 hours later. 
Histological examination revealed mixt 
pituitary adenoma most of the tumoral 
fragments were represented by necrotic 
tissue highly suggestive for pituitary 
apoplexy. (Figure 3) 
Postoperatory course 
Immediately after the operation the 
patient noted the improvement of the visual 
acuity on both eyes. 48 hours later the third 
nerve palsy had completely resolved. 
Patient had transient diabetes insipidus but 
she was discharged from hospital in good 
condition; she was completely oriented and 
she had no other neurological signs. 
One month later the patient presents to 
our clinic with headache, dizziness, 
vomiting. CT scans revealed increase in size 
of ventricular system. (Figure 4) The 
patient was diagnosed with 
posthemorrhagic hydrocephalus and a 
ventriculo-peritoneal shunt was made with 
symptoms relief. (Figure 5) The 
endocrinological evaluation revealed 
normal values. 
 
 
Figure 3 Histopathological features  
of pituitary apoplexy 
 
Figure 4 Cerebral CT scan: posthemorrhagic 
hydrocephalus 
 
 
 
 
Figure 5 Cerebral CT scan: postoperatory status,  
6 month after surgery 
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Discussion 
Pituitary apoplexy is a clinical syndrome 
determined by the rapid expansion of an 
infarcted and/or hemorrhagic pituitary 
adenoma that extends laterally to the 
cavernous sinus or superiorly to displace 
the chiasm or optic nerves. The clinical 
syndrome is characterized by sudden onset 
of a severe headache, nausea, vertigo, 
meningismus, decreased level of 
consciousness, ophtalmoplegia, restriction 
of visual field, decreased visual acuity. (7, 
11) 
Bailey described the first case of pituitary 
tumor associated with hemorrhage in 1898; 
in 1950, Brougham and colleagues called 
the signs and symptoms due to necrosis and 
/ or hemorrhage “pituitary apoplexy – the 
second syllable of the suffix “plexy” means 
“to have a stroke” and comes from Greek 
language.(11) 
Pituitary adenoma represents 
approximately 10% of intracranial tumors; 
the reported incidence of pituitary apoplexy 
in these lesions is 2-7%. (2) 
All types of tumor have the same risk to 
develop apoplexy. Approximately 50% of 
apoplectic events occur in patients who 
were not previously known to have 
pituitary tumors, consequently the 
diagnosis is delayed. The age range of 
affected patients stretches from the first to 
the eighth decade, with the most cases in 
the fifth and sixth decade. Men are affected 
more commonly than the women in most 
series. Wakai, et al., found in their 
retrospective review that 16.6% of patients 
with pituitary adenoma had degenerated 
blood or intratumoral hematoma and only 
6.8% experienced an apoplectic event. (12) 
Deb noted that hemorrhage was observed 
during surgical intervention in 17.1% and 
only 5.4% had clinically signs and 
symptoms. (12) 
The most frequent signs and 
symptoms of pituitary tumor apoplexy 
are headache (frontal or retroorbitar), 
restriction of vizual field, decrease in visual 
acuity, ophtalmoplegia, nausea, vomiting, 
vertigo, meningismus, decreased level of 
consciousness, facial pain or altered or 
impared facial sensation, fever, hemiparesis, 
horner syndrome, seizure. (7)  
Hormonal abnormalities are 
frequently found in pituitary apoplexy. 
Hipopituitarism, with variably decreased 
levels of all hormones is due to increased 
intrasellar pressure, destruction of the gland 
or preexisting deficits from an adenoma. 
Vedhuis and Hammond observed that after 
an episode of pituitary apoplexy, 88% of 
patients lacked sufficient growth hormone, 
76% adequate amounts of lutenizing 
hormone, 67% sufficient prolactin, and 66% 
enough adrenocorticotropic hormone, and 
that 33% of patients experienced 
deficiencies in estradiol. (11) 
Diabetes insipidus is an uncommon 
sequela to pituitary apoplexy and occures as 
a result of impingement on the 
intracavernous portion of the inferior 
hypophysial artery, causing diminished 
perfusion to the posterior lobe. Another 
cause of diabetes insipidus is the 
compression of the infundibulum by the 
edematous, hemorrhagic material which 
impedes transit antidiuretic hormone from 
the preoptic and paraventricular nuclei of 
the hypothalamus. Verrees and Baha noted 
that diabetes insipidus occurred in only 2% 
to 3% of patients examinated for this 
disorder. (11) 
Precipitating factors have been 
identified in approximately 50% of cases of 
pituitary apoplexy. The most frequent 
factors incriminated in the occurrence of 
pituitary apoplexy are: head trauma, 
bromocriptine administration or 
withdrawal, anticoagulation, pregnancy, 
cardiac bypass, bowel or other general 
surgery, atherosclerosis, diabetic 
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ketoacidosis, estrogen therapy, radiation 
therapy, hypertension or hypotension. In 
our case none of these factors was the cause 
of the sudden onset of the symptomes. (11) 
An important number of publications 
have reported that necrosis and hemorrage 
are more frequent in voluminous tumors 
due to the discrepancy between the rate of 
neoplastic progresion and the availability of 
circulary imput. Nevertheless small tumors 
also hemorrhage. Biousse and associates 
reported increased demand on the pituitary 
coupled with blood pressure fluctuations as 
an inciting factor in the generation of 
pituitary tumor apoplexy. Ebersold, et al., 
have emphasized vascular stasis and 
subsequent thrombosis as the likely 
mechanism eliciting necrosis and 
subsequent bleeding. (3) 
Pituitary adenoma represents 10% of 
intracranial tumors but pituitary adenomas 
constitute a greater proportion of tumor 
related hemorrhage. Glass and Abbott 
reported thar only 25% of intracranial 
hemorrhage originated secondary to 
adenomas compared with 50% instigated by 
gliomas, which are five times more 
common. Wakai, et al., discovered that 
adenomas are 5.4 times more likely to 
bleed. (4) 
Computerized tomography scans 
may reveal the hyperdensity of acute 
hemorrhage if obtained within 3 to 4 days 
after the acute event or show the mixed 
density of acute blood and hypodense 
necrotic tissue. subarachnoid hemorrhage 
can be evident if blood has invaded the 
basal cisterns. (10) 
Magnetic resonance imaging is the 
most effective neuroimaging method for 
diagnosing pituitary apoplexy. Piotin, et al., 
in their series, in which MR imaging 
studies were obtained in 11 patients with 
pituitary apoplexy, concluded that this 
disease may present with varying MR 
imaging features, including 
nonhemorrhagic and hemorrhagic changes 
on T1-wighted images. The greater 
sensitivity, precision, and tissue definition 
of MR imaging reveal the heterogeneous 
intensity of hemorrhage, edematous 
pituitary gland, and necrotic tumor leading 
to diagnosis. The multiplanar capability of 
this imaging investigation allows 
characterization of the extend of necrosis 
and/or hemorrhage and evaluations of the 
relationship of hemorrhage and 
surrounding neurovascular structures. K. 
Arita, et al., noted a serial of changes of the 
parasellar dura mater. These changes are 
caused by congestion of the dural blood 
flow, probably because of the increased 
pressure in the cavernous or circular sinus. 
He also noted a thickening of the sphenoid 
sinus mucosa due to venous congestion 
caused by obstruction of transsellar venous 
flow. Another cause may be the 
inflammatory reaction of the sphenoid 
sinus mucosa; the inflammatory substances 
produced by the necrotic adenoma tissue 
intermingled with blood clots during 
pituitary apoplexy. These inflammatory 
substances reach the sphenoid sinus by 
diffusion or by venous flow through an 
erodated sellar floor. (6, 8) 
It is important to recognize apoplexy on 
CT scans because the CT scans are 
obtained initially when patients present to 
the emergency room with nonspecific 
neurological signs and symptoms. (10) 
Differential diagnosis of pituitary 
apoplexy must be made with: SAH from 
aneurysmal rupture, viral or bacterial 
meningitis, spontaneous hemorrhage 
(hypertensive or amyloid bleeding or from 
a metastatic tumor or primary lezion), 
cavernous sinus thrombosis, carotid- 
cavernous fistula, transtentorial herniation, 
vertebrobasilar insufficiency, optic neuritis, 
diabetic oculomotor palsy, migraine, 
temporal arteritis. (5, 12) 
Standard therapy of pituitary apoplexy 
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includes: high-dose steroid treatment, 
which can improve symptoms in a few 
days, and surgical decompression via 
transsphenoidal route, if symptoms are 
severe or rapidly progressive. 
The pituitary gland is capable of 
secreting adequate amounts of hormones 
when as little as 10% of the gland remains; 
insufficient secretion of hormones can lead 
to adrenal crisis. Intravenous steroid 
administration should start immediately, 
one hundred milligrams of hydrocortisone 
can be administrated until the correct 
diagnosis is established. (10) 
The definitive therapy for pituitary 
apoplexy is surgery for decompression of 
compressed cavernous sinus or suprasellar 
structures, especially when the visual acuity 
or field defects, decreased level of 
consciousness are present, or when the 
symptoms are progressive. The 
transsphenoidal approach is a safe and 
efficient treatment of pituitary apoplexy 
because the optic pathway which is severely 
compressed and becomes edematous during 
the acute stage of pituitary apoplexy is not 
directly manipulated. (9) 
An intracranial approach may be 
recommended when there is an important 
hemispheric extension of hemorrhage, the 
presence of hemorrhage and/or necrosis 
extending distal to constricted diaphragma 
sella, or the existence of a poorly aerated 
sphenoid sinus. (11) 
Conclusions 
Pituitary apoplexy remains a potentially 
life-threatening disease. Its presentation 
may vary from relatively benign symptoms 
to major neurological deficits and even 
death.  
Its early recognition and treatment are 
vital. (2, 11) 
 
 
Abreviation 
SAH - subarachnoid hemorrhage 
CT – computerized tomography 
MR – magnetic resonance 
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